83 studies found for:    "Bacterial meningitis"
Show Display Options
Rank Status Study
1 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
2 Completed Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Glycerol and paracetamol;   Drug: Paracetamol;   Drug: Placebo;   Drug: Paracetamol and glycerol;   Drug: Glycerol
3 Recruiting Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae
Condition: Meningitis, Bacterial
Intervention:
4 Active, not recruiting Infant Severe Sepsis and Bacterial Meningitis in Malawi
Condition: Infant Bacterial Meningitis
Intervention: Drug: Ceftriaxone v penicillin and gentamicin
5 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
6 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
7 Recruiting DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Inf
Conditions: Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis;   Bacterial Meningitis
Interventions: Biological: DTaP-IPV/Hib Combined vaccine;   Biological: DTaP-IPV vaccine and Hib vaccine
8 Completed Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
9 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
10 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Conditions: Neurological Disorders;   Cerebral Malaria;   Bacterial Meningitis;   Central Nervous System Tuberculosis;   Neurosyphilis;   Cryptococcal Meningitis
Interventions: Device: Immunochromatographic HAT tests (DSD);   Device: Card Agglutination Trypanosoma Test;   Device: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics);   Device: TB 3-marker RDT (Tulip diagnostics);   Device: Cryptococcal Antigen Lateral Flow Assay (Immy)
11 Withdrawn Amikacin Penetration Into the Cerebrospinal Fluid
Conditions: Gram Negative Meningitis;   Post Traumatic Bacterial Meningitis
Intervention: Drug: Systemic and Intra-Thecal Amikacin Therapy
12 Completed Safety and Immunogencitiy Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)
Conditions: Neisseria Meningitidis (Bacterial Meningitis);   Invasive Pneumococcal Disease (IPD)
Interventions: Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)
13 Suspended Daptomycin in Pediatric Patients With Bacterial Meningitis
Conditions: Meningitis;   Gram-Positive Bacteria
Intervention: Drug: Daptomycin
14 Completed Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
15 Completed
Has Results
Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers
Conditions: Meningococcal Meningitis;   Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate;   Biological: Measles-mumps-rubella-varicella vaccine;   Biological: Routine paediatric vaccine - Pneumococcal conjugate (PCV) and Hepatitis A
16 Completed Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Meningococcal ABCWY Vaccine
17 Active, not recruiting A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Recombinant meningococcal B + OMV NZ
18 Not yet recruiting Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos
Condition: Meningitis, Meningococcal, Serogroup C
Interventions: Biological: 'MenCC-Bio';   Biological: MENJUGATE
19 Completed Study to Evaluate GlaxoSmithKline (GSK) Biologicals’ MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers
Condition: Meningitis, Haemophilus
Interventions: Biological: MenC-TT;   Biological: Hib-MenC-TT
20 Completed Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults
Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine candidate;   Procedure: Blood draw

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years